vs
Side-by-side financial comparison of Fresenius Medical Care AG (FMS) and Mastercard (MA). Click either name above to swap in a different company.
Mastercard is the larger business by last-quarter revenue ($8.8B vs $5.5B, roughly 1.6× Fresenius Medical Care AG). Mastercard runs the higher net margin — 46.1% vs 7.9%, a 38.2% gap on every dollar of revenue. On growth, Mastercard posted the faster year-over-year revenue change (17.6% vs -0.3%).
Fresenius Medical Care AG & Co. KGaA is a German healthcare company which provides kidney dialysis services through a network of 4,171 outpatient dialysis centers, serving 345,425 patients. The company primarily treats end-stage renal disease (ESRD), which requires patients to undergo dialysis 3 times per week for the rest of their lives.
Mastercard Inc. is an American multinational payment card services corporation headquartered in Purchase, New York. It offers a range of payment transaction processing and other related-payment services. Throughout the world, its principal business is to process payments between the banks of merchants and the card-issuing banks or credit unions of the purchasers who use the Mastercard-brand debit, credit and prepaid cards to make purchases. Mastercard has been publicly traded since 2006.
FMS vs MA — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $5.5B | $8.8B |
| Net Profit | $434.2M | $4.1B |
| Gross Margin | 27.4% | — |
| Operating Margin | 11.7% | 55.8% |
| Net Margin | 7.9% | 46.1% |
| Revenue YoY | -0.3% | 17.6% |
| Net Profit YoY | 240.4% | 21.5% |
| EPS (diluted) | — | $4.52 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $5.5B | $8.8B | ||
| Q3 25 | — | $8.6B | ||
| Q2 25 | — | $8.1B | ||
| Q1 25 | — | $7.3B | ||
| Q4 24 | $5.5B | $7.5B | ||
| Q3 24 | — | $7.4B | ||
| Q2 24 | — | $7.0B | ||
| Q1 24 | — | $6.3B |
| Q4 25 | $434.2M | $4.1B | ||
| Q3 25 | — | $3.9B | ||
| Q2 25 | — | $3.7B | ||
| Q1 25 | — | $3.3B | ||
| Q4 24 | $127.6M | $3.3B | ||
| Q3 24 | — | $3.3B | ||
| Q2 24 | — | $3.3B | ||
| Q1 24 | — | $3.0B |
| Q4 25 | 27.4% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 25.0% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | 11.7% | 55.8% | ||
| Q3 25 | — | 58.8% | ||
| Q2 25 | — | 58.7% | ||
| Q1 25 | — | 57.2% | ||
| Q4 24 | 5.1% | 52.6% | ||
| Q3 24 | — | 54.3% | ||
| Q2 24 | — | 58.0% | ||
| Q1 24 | — | 56.8% |
| Q4 25 | 7.9% | 46.1% | ||
| Q3 25 | — | 45.7% | ||
| Q2 25 | — | 45.5% | ||
| Q1 25 | — | 45.2% | ||
| Q4 24 | 2.3% | 44.6% | ||
| Q3 24 | — | 44.3% | ||
| Q2 24 | — | 46.8% | ||
| Q1 24 | — | 47.4% |
| Q4 25 | — | $4.52 | ||
| Q3 25 | — | $4.34 | ||
| Q2 25 | — | $4.07 | ||
| Q1 25 | — | $3.59 | ||
| Q4 24 | — | $3.64 | ||
| Q3 24 | — | $3.53 | ||
| Q2 24 | — | $3.50 | ||
| Q1 24 | — | $3.22 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.7B | $10.6B |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $15.4B | $7.7B |
| Total Assets | $33.5B | $54.2B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.7B | $10.6B | ||
| Q3 25 | — | $10.3B | ||
| Q2 25 | — | $9.0B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | $1.3B | $8.4B | ||
| Q3 24 | — | $11.1B | ||
| Q2 24 | — | $7.0B | ||
| Q1 24 | — | $7.3B |
| Q4 25 | $15.4B | $7.7B | ||
| Q3 25 | — | $7.9B | ||
| Q2 25 | — | $7.9B | ||
| Q1 25 | — | $6.7B | ||
| Q4 24 | $17.0B | $6.5B | ||
| Q3 24 | — | $7.4B | ||
| Q2 24 | — | $7.4B | ||
| Q1 24 | — | $7.2B |
| Q4 25 | $33.5B | $54.2B | ||
| Q3 25 | — | $53.3B | ||
| Q2 25 | — | $51.4B | ||
| Q1 25 | — | $48.5B | ||
| Q4 24 | $36.3B | $48.1B | ||
| Q3 24 | — | $47.2B | ||
| Q2 24 | — | $42.3B | ||
| Q1 24 | — | $42.6B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $2.9B | $5.0B |
| Free Cash FlowOCF − Capex | — | $4.9B |
| FCF MarginFCF / Revenue | — | 55.5% |
| Capex IntensityCapex / Revenue | — | 1.3% |
| Cash ConversionOCF / Net Profit | 6.67× | 1.23× |
| TTM Free Cash FlowTrailing 4 quarters | — | $17.2B |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $2.9B | $5.0B | ||
| Q3 25 | — | $5.7B | ||
| Q2 25 | — | $4.6B | ||
| Q1 25 | — | $2.4B | ||
| Q4 24 | $2.6B | $4.8B | ||
| Q3 24 | — | $5.1B | ||
| Q2 24 | — | $3.1B | ||
| Q1 24 | — | $1.7B |
| Q4 25 | — | $4.9B | ||
| Q3 25 | — | $5.5B | ||
| Q2 25 | — | $4.6B | ||
| Q1 25 | — | $2.2B | ||
| Q4 24 | — | $4.7B | ||
| Q3 24 | — | $5.0B | ||
| Q2 24 | — | $3.0B | ||
| Q1 24 | — | $1.5B |
| Q4 25 | — | 55.5% | ||
| Q3 25 | — | 63.8% | ||
| Q2 25 | — | 56.1% | ||
| Q1 25 | — | 30.6% | ||
| Q4 24 | — | 63.3% | ||
| Q3 24 | — | 68.2% | ||
| Q2 24 | — | 43.4% | ||
| Q1 24 | — | 23.9% |
| Q4 25 | — | 1.3% | ||
| Q3 25 | — | 2.1% | ||
| Q2 25 | — | 0.5% | ||
| Q1 25 | — | 2.2% | ||
| Q4 24 | — | 1.3% | ||
| Q3 24 | — | 1.5% | ||
| Q2 24 | — | 1.7% | ||
| Q1 24 | — | 2.5% |
| Q4 25 | 6.67× | 1.23× | ||
| Q3 25 | — | 1.44× | ||
| Q2 25 | — | 1.24× | ||
| Q1 25 | — | 0.73× | ||
| Q4 24 | 20.20× | 1.45× | ||
| Q3 24 | — | 1.57× | ||
| Q2 24 | — | 0.96× | ||
| Q1 24 | — | 0.56× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FMS
Segment breakdown not available.
MA
| Payment Network | $4.9B | 56% |
| Value Added Services And Solutions | $3.9B | 44% |
